The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Cullinan Oncology, Inc(NASDAQ:CGEM) 
Cullinan Management, Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalati...
Website: https://www.cullinanoncology.com/
Founded: 2016
CEO: Owen Hughes
Sector: Pharmaceuticals
Industry:
Share this website to your friends
Cullinan Oncology Days Payable Outstanding ttm (DPO)
Cullinan Oncology Days Inventory Outstanding ttm (DIO)
Cullinan Oncology Op Cashflow Per Share ttm
Cullinan Oncology Free Cashflow Per Share ttm
Cullinan Oncology Cash Per Share ttm
Cullinan Oncology P/S ratio ttm
Cullinan Oncology (GAAP) P/E ratio ttm
Cullinan Oncology P/B ratio ttm
No extra charts and metrics for this ticker.